KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Research & Development: 2009-2024

Historic Research & Development for Incyte (INCY) over the last 16 years, with Dec 2024 value amounting to $2.6 billion.

  • Incyte's Research & Development fell 11.62% to $506.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year decrease of 26.32%. This contributed to the annual value of $2.6 billion for FY2024, which is 60.17% up from last year.
  • As of FY2024, Incyte's Research & Development stood at $2.6 billion, which was up 60.17% from $1.6 billion recorded in FY2023.
  • In the past 5 years, Incyte's Research & Development registered a high of $2.6 billion during FY2024, and its lowest value of $1.5 billion during FY2021.
  • In the last 3 years, Incyte's Research & Development had a median value of $1.6 billion in 2023 and averaged $1.9 billion.
  • Its Research & Development has fluctuated over the past 5 years, first soared by 92.00% in 2020, then tumbled by 34.20% in 2021.
  • Yearly analysis of 5 years shows Incyte's Research & Development stood at $2.2 billion in 2020, then slumped by 34.20% to $1.5 billion in 2021, then climbed by 8.76% to $1.6 billion in 2022, then rose by 2.63% to $1.6 billion in 2023, then spiked by 60.17% to $2.6 billion in 2024.